MARKER THERAPEUTICS, INC. Investment Income, Interest
MARKER THERAPEUTICS, INC. (MRKR) reported Investment Income, Interest of $112.56 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-14
- MARKER THERAPEUTICS, INC. investment income, interest for the quarter ending 2026-06-30 was $112.56K, a 12.08% decline year-over-year.
- MARKER THERAPEUTICS, INC. investment income, interest for the quarter ending 2026-03-31 was $132.89K, a 18.22% decline year-over-year.
- MARKER THERAPEUTICS, INC. investment income, interest for the quarter ending 2025-12-31 was $165.63K, a 124.59% increase year-over-year.
- MARKER THERAPEUTICS, INC. investment income, interest for the quarter ending 2025-09-30 was $138.06K, a 50.59% increase year-over-year.
- MARKER THERAPEUTICS, INC. investment income, interest for fiscal 2025 was $594.21K, a 35.97% increase from fiscal 2024.
- MARKER THERAPEUTICS, INC. investment income, interest for fiscal 2024 was $437.01K, a 18.95% decline from fiscal 2023.
- MARKER THERAPEUTICS, INC. investment income, interest for fiscal 2023 was $539.16K, a 117.35% increase from fiscal 2022.
- MARKER THERAPEUTICS, INC. investment income, interest for fiscal 2022 was $248.06K, a 4251.98% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 12 month | Investment Income, Interest 143 month | Investment Income, Interest 146 month | Investment Income, Interest 149 month | Investment Income, Interest 152 month | Investment Income, Interest 155 month | Investment Income, Interest 158 month | Investment Income, Interest 161 month | Investment Income, Interest 164 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $112.56K 10-Q · filed 2026-08-14 | $245.45K 10-Q · filed 2026-08-14 | $411.07K derived: sum of 3 quarters · filed 2026-08-14 | $549.14K derived: sum of 4 quarters · filed 2026-08-14 | |||||||||
| 2026-03-31 | $132.89K 10-Q · filed 2026-05-15 | $298.52K derived: sum of 2 quarters · filed 2026-05-15 | $436.58K derived: sum of 3 quarters · filed 2026-05-15 | $564.61K derived: sum of 4 quarters · filed 2026-08-14 | |||||||||
| 2025-12-31 | $165.63K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $303.69K derived: sum of 2 quarters · filed 2026-03-18 | $431.72K derived: sum of 3 quarters · filed 2026-08-14 | $594.21K 10-K · filed 2026-03-18 | |||||||||
| 2025-09-30 | $138.06K 10-Q · filed 2025-11-13 | $266.09K derived: sum of 2 quarters · filed 2026-08-14 | $428.58K 10-Q · filed 2025-11-13 | $502.32K derived: sum of 4 quarters · filed 2026-08-14 | |||||||||
| 2025-06-30 | $128.03K 10-Q · filed 2026-08-14 | $290.51K 10-Q · filed 2026-08-14 | $364.26K derived: sum of 3 quarters · filed 2026-08-14 | $455.94K derived: sum of 4 quarters · filed 2026-08-14 | |||||||||
| 2025-03-31 | $162.49K 10-Q · filed 2026-05-15 | $236.24K derived: sum of 2 quarters · filed 2026-05-15 | $327.92K derived: sum of 3 quarters · filed 2026-05-15 | $443.30K derived: sum of 4 quarters · filed 2026-05-15 | |||||||||
| 2024-12-31 | $73.75K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $165.43K derived: sum of 2 quarters · filed 2026-03-18 | $280.81K derived: sum of 3 quarters · filed 2026-03-18 | $437.01K 10-K · filed 2026-03-18 | |||||||||
| 2024-09-30 | $91.68K 10-Q · filed 2025-11-13 | $207.07K derived: sum of 2 quarters · filed 2025-11-13 | $363.26K 10-Q · filed 2025-11-13 | $564.60K derived: sum of 4 quarters · filed 2025-11-13 | |||||||||
| 2024-06-30 | $115.39K 10-Q · filed 2025-08-14 | $271.58K 10-Q · filed 2025-08-14 | $472.92K derived: sum of 3 quarters · filed 2025-08-14 | $691.01K derived: sum of 4 quarters · filed 2025-08-14 | |||||||||
| 2024-03-31 | $156.19K 10-Q · filed 2025-05-15 | $357.53K derived: sum of 2 quarters · filed 2025-05-15 | $575.62K derived: sum of 3 quarters · filed 2025-05-15 | $610.70K derived: sum of 4 quarters · filed 2025-05-15 | |||||||||
| 2023-12-31 | $201.34K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $419.42K derived: sum of 2 quarters · filed 2025-03-31 | $454.50K derived: sum of 3 quarters · filed 2025-03-31 | $539.16K 10-K · filed 2025-03-31 | |||||||||
| 2023-09-30 | $218.09K 10-Q · filed 2024-11-14 | $253.16K derived: sum of 2 quarters · filed 2024-11-14 | $337.82K 10-Q · filed 2024-11-14 | $447.23K derived: sum of 4 quarters · filed 2024-11-14 | |||||||||
| 2023-06-30 | $35.08K 10-Q · filed 2024-08-14 | $119.73K 10-Q · filed 2024-08-14 | $229.14K derived: sum of 3 quarters · filed 2024-08-14 | $328.89K derived: sum of 4 quarters · filed 2024-08-14 | |||||||||
| 2023-03-31 | $84.65K 10-Q · filed 2024-05-15 | $194.06K derived: sum of 2 quarters · filed 2024-05-15 | $293.81K derived: sum of 3 quarters · filed 2024-05-15 | $329.60K derived: sum of 4 quarters · filed 2024-05-15 | |||||||||
| 2022-12-31 | $109.41K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $209.16K derived: sum of 2 quarters · filed 2024-03-26 | $244.95K derived: sum of 3 quarters · filed 2024-03-26 | $248.06K 10-K · filed 2024-03-26 | |||||||||
| 2022-09-30 | $99.75K 10-Q · filed 2023-11-09 | $135.54K derived: sum of 2 quarters · filed 2023-11-09 | $138.65K 10-Q · filed 2023-11-09 | $139.62K derived: sum of 4 quarters · filed 2023-11-09 | |||||||||
| 2022-06-30 | $35.79K 10-Q · filed 2023-08-14 | $38.90K 10-Q · filed 2023-08-14 | $38.90K 10-Q · filed 2022-08-11 | $39.87K derived: sum of 3 quarters · filed 2023-08-14 | $40.66K derived: sum of 4 quarters · filed 2023-08-14 | ||||||||
| 2022-03-31 | $3.12K 10-Q · filed 2023-05-15 | $4.09K derived: sum of 2 quarters · filed 2023-05-15 | $4.88K derived: sum of 3 quarters · filed 2023-05-15 | $7.28K derived: sum of 4 quarters · filed 2023-05-15 | |||||||||
| 2021-12-31 | $969.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $1.76K derived: sum of 2 quarters · filed 2023-03-22 | $4.16K derived: sum of 3 quarters · filed 2023-03-22 | $5.70K 10-K · filed 2023-03-22 | |||||||||
| 2021-09-30 | $791.00 10-Q · filed 2022-11-10 | $3.19K derived: sum of 2 quarters · filed 2022-11-10 | $4.73K 10-Q · filed 2022-11-10 | $5.98K derived: sum of 4 quarters · filed 2022-11-10 | |||||||||
| 2021-06-30 | $2.40K 10-Q · filed 2022-08-11 | $3.94K 10-Q · filed 2022-08-11 | $5.19K derived: sum of 3 quarters · filed 2022-08-11 | $9.86K derived: sum of 4 quarters · filed 2022-08-11 | |||||||||
| 2021-03-31 | $1.54K 10-Q · filed 2022-05-13 | $2.79K derived: sum of 2 quarters · filed 2022-05-13 | $7.45K derived: sum of 3 quarters · filed 2022-05-13 | $23.31K derived: sum of 4 quarters · filed 2022-05-13 | |||||||||
| 2020-12-31 | $1.25K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $5.92K derived: sum of 2 quarters · filed 2022-03-17 | $21.77K derived: sum of 3 quarters · filed 2022-03-17 | $148.74K 10-K · filed 2022-03-17 | |||||||||
| 2020-09-30 | $4.67K 10-Q · filed 2021-11-10 | $20.52K derived: sum of 2 quarters · filed 2021-11-10 | $147.49K 10-Q · filed 2021-11-10 | $332.37K derived: sum of 4 quarters · filed 2021-11-10 | |||||||||
| 2020-06-30 | $15.86K 10-Q · filed 2021-08-10 | $142.83K 10-Q · filed 2021-08-10 | $327.70K derived: sum of 3 quarters · filed 2021-08-10 | $586.95K derived: sum of 4 quarters · filed 2021-08-10 | |||||||||
| 2020-03-31 | $126.97K 10-Q · filed 2021-05-12 | $311.84K derived: sum of 2 quarters · filed 2021-05-12 | $571.09K derived: sum of 3 quarters · filed 2021-05-12 | $881.27K derived: sum of 4 quarters · filed 2021-05-12 | |||||||||
| 2019-12-31 | $184.88K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $444.12K derived: sum of 2 quarters · filed 2021-03-09 | $754.30K derived: sum of 3 quarters · filed 2021-03-09 | $1.08M 10-K · filed 2021-03-09 | |||||||||
| 2019-09-30 | $259.25K 10-Q · filed 2020-11-09 | $569.42K derived: sum of 2 quarters · filed 2020-11-09 | $897.97K 10-Q · filed 2020-11-09 | $1.15M derived: sum of 4 quarters · filed 2020-11-09 | |||||||||
| 2019-06-30 | $310.17K 10-Q · filed 2020-08-10 | $638.72K 10-Q · filed 2020-08-10 | $892.44K derived: sum of 3 quarters · filed 2020-08-10 | $892.44K derived: sum of 4 quarters · filed 2020-08-10 | |||||||||
| 2019-03-31 | $328.55K 10-Q · filed 2020-05-11 | $582.27K derived: sum of 2 quarters · filed 2020-05-11 | $582.27K derived: sum of 3 quarters · filed 2020-05-11 | $582.27K derived: sum of 4 quarters · filed 2020-05-11 | |||||||||
| 2018-12-31 | $253.72K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $253.72K derived: sum of 2 quarters · filed 2020-03-12 | $253.72K derived: sum of 3 quarters · filed 2020-03-12 | $253.72K 10-K · filed 2020-03-12 | |||||||||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | ||||||||||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | |||||||||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-10 | ||||||||||||
| 2017-12-31 | $0.00 10-K · filed 2019-03-15 | ||||||||||||
| 2013-03-31 | $33.34K 10-Q · filed 2013-05-21 | ||||||||||||
| 2012-12-31 | $33.34K 10-K · filed 2013-05-15 | ||||||||||||
| 2012-09-30 | $33.34K 10-Q · filed 2012-11-19 | ||||||||||||
| 2012-06-30 | $0.00 10-Q/A · filed 2012-09-12 | $0.00 10-Q/A · filed 2012-09-12 | $33.34K 10-Q/A · filed 2012-09-12 | ||||||||||
| 2012-03-31 | $33.34K 10-Q · filed 2012-05-21 | ||||||||||||
| 2011-12-31 | $33.34K 10-K · filed 2012-04-16 | ||||||||||||
| 2011-09-30 | $33.34K 10-Q · filed 2011-11-21 | ||||||||||||
| 2011-06-30 | $0.00 10-Q/A · filed 2012-09-12 | $0.00 10-Q/A · filed 2012-09-12 | $33.34K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |